1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25 | On this day 11/1/2022, Licensing Program Analyst (LPA) C. Lin conducted a case management visit and met with Executive Director. LPA explained the purpose of the visit.
During an investigation conducted by the Department, records obtained indicated that facility staff assisted resident R1 for self-administering medicine Morphine from 5/17/22 to 5/21/22 where was documented on R1's Medication Administration Records (MAR). R1's Hospice Care Plan clearly indicated that "Do not use until directed by hospice".
A deficiency was observed (see LIC809D) and cited from the California Code of Regulation, Title 22. Failure to correct the deficiency may result in civil penalty.
Exit interview conducted with Executive Director. A copy of this report and Appeal Rights were provided. |